1. Home
  2. VCEL vs CYD Comparison

VCEL vs CYD Comparison

Compare VCEL & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • CYD
  • Stock Information
  • Founded
  • VCEL 1989
  • CYD 1951
  • Country
  • VCEL United States
  • CYD Singapore
  • Employees
  • VCEL N/A
  • CYD N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • CYD Industrial Machinery/Components
  • Sector
  • VCEL Health Care
  • CYD Industrials
  • Exchange
  • VCEL Nasdaq
  • CYD Nasdaq
  • Market Cap
  • VCEL 1.6B
  • CYD 1.5B
  • IPO Year
  • VCEL 1997
  • CYD 1994
  • Fundamental
  • Price
  • VCEL $33.59
  • CYD $38.04
  • Analyst Decision
  • VCEL Strong Buy
  • CYD
  • Analyst Count
  • VCEL 6
  • CYD 0
  • Target Price
  • VCEL $58.60
  • CYD N/A
  • AVG Volume (30 Days)
  • VCEL 703.6K
  • CYD 297.2K
  • Earning Date
  • VCEL 11-06-2025
  • CYD 08-08-2025
  • Dividend Yield
  • VCEL N/A
  • CYD 1.39%
  • EPS Growth
  • VCEL 2045.40
  • CYD 40.10
  • EPS
  • VCEL 0.13
  • CYD 1.66
  • Revenue
  • VCEL $249,119,000.00
  • CYD $3,159,401,156.00
  • Revenue This Year
  • VCEL $18.35
  • CYD $42.20
  • Revenue Next Year
  • VCEL $22.26
  • CYD $5.06
  • P/E Ratio
  • VCEL $259.38
  • CYD $23.46
  • Revenue Growth
  • VCEL 16.13
  • CYD 17.99
  • 52 Week Low
  • VCEL $29.24
  • CYD $8.61
  • 52 Week High
  • VCEL $63.00
  • CYD $42.60
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 52.73
  • CYD 51.33
  • Support Level
  • VCEL $31.34
  • CYD $35.31
  • Resistance Level
  • VCEL $35.70
  • CYD $39.46
  • Average True Range (ATR)
  • VCEL 1.48
  • CYD 2.03
  • MACD
  • VCEL 0.46
  • CYD -0.59
  • Stochastic Oscillator
  • VCEL 71.12
  • CYD 39.73

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: